AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2010
Sep 29, 2010
30826_dirs_2010-09-29_e6824ebf-bb37-4b14-b8dc-cf85fc396369.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2010-07-15
Reporting Person: Kelly William J (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-07-15 | Stock Option (Right to Buy) | $3.33 | A | 25000 | Acquired | 2020-07-15 | Common Stock (25000) | Direct |
Footnotes
F1: 5,000 shares vest and become exercisable on each of the following dates: 7/15/2011, 7/15/2012, 7/15/2013, 7/15/2014 and 7/15/2015.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23